Lysophosphatidic acid receptor mRNA levels in heart and white adipose tissue are associated with obesity in mice and humans

• Published in: PloS one Vol. 12; no. 12; p. e0189402
• Main Authors: Brown, Amy, Hossain, Intekhab, Perez, Lester J, Nzirorera, Carine, Tozer, Kathleen, D'Souza, Kenneth, Trivedi, Purvi C, Aguiar, Christie, Yip, Alexandra M, Shea, Jennifer, Brunt, Keith R, Legare, Jean-Francois, Hassan, Ansar, Pulinilkunnil, Thomas, Kienesberger, Petra C
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 13.12.2017; Public Library of Science (PLoS)
• Subjects: Acids; Adipocytes; Adipose tissue; Biochemistry; Biology and Life Sciences; Body fat; Cardiomyocytes; Correlation analysis; Diagnosis; Disease; Gene expression; Genetic aspects; Glucose; Heart; Heart attacks; Heart diseases; Heart failure; Heart surgery; Homeostasis; Hospitals; Inflammation; Insulin; Insulin resistance; Lipids; Liver cancer; Lysophosphatidic acid; Measurement; Medicine; Medicine and Health Sciences; Messenger RNA; Metabolic disorders; Mice; Mimicry; Molecular biology; Myocardium; Obesity; Palmitic acid; Patients; Physiological aspects; Receptors; Risk factors; Rodents; Signaling; Studies; Sucrose; Sugar; Surgery; Canada
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0189402

Lysophosphatidic acid (LPA) receptor signaling has been implicated in cardiovascular and obesity-related metabolic disease. However, the distribution and regulation of LPA receptors in the myocardium and adipose tissue remain unclear. This study aimed to characterize the mRNA expression of LPA receptors (LPA1-6) in the murine and human myocardium and adipose tissue, and its regulation in response to obesity. LPA receptor mRNA levels were determined by qPCR in i) heart ventricles, isolated cardiomyocytes, and perigonadal adipose tissue from chow or high fat-high sucrose (HFHS)-fed male C57BL/6 mice, ii) 3T3-L1 adipocytes and HL-1 cardiomyocytes under conditions mimicking gluco/lipotoxicity, and iii) human atrial and subcutaneous adipose tissue from non-obese, pre-obese, and obese cardiac surgery patients. LPA1-6 were expressed in myocardium and white adipose tissue from mice and humans, except for LPA3, which was undetectable in murine adipocytes and human adipose tissue. Obesity was associated with increased LPA4, LPA5 and/or LPA6 levels in mice ventricles and cardiomyocytes, HL-1 cells exposed to high palmitate, and human atrial tissue. LPA4 and LPA5 mRNA levels in human atrial tissue correlated with measures of obesity. LPA5 mRNA levels were increased in HFHS-fed mice and insulin resistant adipocytes, yet were reduced in adipose tissue from obese patients. LPA4, LPA5, and LPA6 mRNA levels in human adipose tissue were negatively associated with measures of obesity and cardiac surgery outcomes. This study suggests that obesity leads to marked changes in LPA receptor expression in the murine and human heart and white adipose tissue that may alter LPA receptor signaling during obesity.